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Abstract We present a 24-year-old female with trauma to her right eye. The patient was prescribed
topical Tobramicin-dexamethasone eye drops but the pharmacy dispensed diclofenac diethyl amine
ointment. The patient presented to the emergency room with lid edema, conjunctival injection and a
corneal epithelial defect and toxic keratitis. The patient was successfully managed with copious
irrigation, bandage contact lens and topical antibiotic therapy.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
he ocular toxicity secondary to topical medications is com-
on after use of anti-glaucoma medications, topical anesthet-
s and to lesser extent topical antibiotics (Al-Ghadeer, 2010;
hen et al., 2004; Vingesh et al., 2015). Nonsteroidal anti-
ﬂammatory drugs (NSAID) also can cause severe ocular sur-
ace complications (Mian et al., 2006).
Systemic medications can cause ocular depositions and tox-
ity, and the Amiodarone is the classical drug which can reach
he eye through the tear ﬁlm and limbal vessels and results in
corneal whorle-like lines called vortex keratopathy (Turk et al.,
2015).
Error of medication treatment process can occur at any stage
which includes prescription, transcription and/or administra-
tion.However, most commonly, medication error occurs during
the prescribing stage and it involves incorrect name, wrong
strength and/or frequency of medication (Alsulami and
Conroy, 2013 April; Kundsen et al., 2007; Berdot et al., 2012).
The errors mostly occurred during the process of transcription
and labeling of the medication (Kundsen et al., 2007) generally
are not long lasting effects (Mansouri et al., 2013).
We present a case of toxic keratitis after use of wrongly
labeled medication at a general hospital.
2. Case report
A 24-year-old female presented to the emergency room at King
Khalid Eye Specialist Hospital (KKESH) complaining of
trauma to her right eye after her son’s ﬁnger contacted the
eye. This resulted in a corneal epithelial defect, and she had
visited an ophthalmologist elsewhere, who had prescribed topi-
cal Tobramicin-dexamethasone combination eye drops to be
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instilled three times a day into the right eye. However, the
pharmacist dispensed an ointment after which she developed
more redness, pain and, tearing after instilling it into her
affected eye on two occasions only. She stopped using the oint-
ment after she discovered that it was (diclofenac diethylamine)
skin ointment. The patient’s medical history was unremark-
able. Visual acuity was 20/20 in both eyes, and the right eye
had mild lid swelling, conjunctival injection and corneal
epithelial defect with surrounding corneal haze (Fig. 1). The
anterior chamber was quiet and the rest of the anterior seg-
ment as well as the posterior segment was unremarkable.
Left eye examination was normal.
Copious eye irrigation was performed in the emergency
room. Her right eye was managed by applying a bandage con-
tact lens and topical antibiotic drops (Oﬂoxacin 0.3% oph-
thalmic solution) were prescribed 4 times per day for a week.
At last follow-up (one month) the corneal defect in the right
eye had completely healed without any signiﬁcant clinical
sequelae. The patient started on Fluorometholone 0.1% eye
drops every 6 h for two weeks after which it was slowly tapered
down with topical antibiotics.
The ointment that the patient had originally instilled in the
eye was diclofenac diethylamine 1.16% (which is equivalent to
ophthalmic diclofenac sodium 1%) in a 50 g emulsion tube
that is usually prescribed to relieve pain, reduce swelling and
combat inﬂammation. Diclofenac diethylamine 1.16% is mar-
keted under the trade name Tabiﬂex (Tabuk Pharmaceutical
Manufacturing Co., Tabuk, Saudi Arabia) (Fig. 2a).
3. Discussion
The ocular toxicity secondary to topical medications has been
heavily discussed but it is concerned to the ophthalmic prepa-
rations such as glaucoma medications, topical anesthetics and
to lesser extent topical antibiotics (Al-Ghadeer, 2010; Chen
et al., 2004; Vingesh et al., 2015).
Most of these preparations exert its toxic effects through
multiple proposed mechanism: directly to create punctate ker-
atopathy, or indirectly by inciting the immune system to create
inﬂammation involving ring shaped stromal inﬁltration as the
case in over use of topical anesthetics and topical nonsteroidal
anti-inﬂammatory drugs NSAID (Chen et al., 2004).
Some of the topical medications can interfere with the
migration of the limbal basal epithelial cells especially if
corneal epithelial defects are present causing delayed healing
and hence stromal inﬁltrations.
Ocular toxicity can appear in the form of corneal edema.
Vingesh et al. (2015) reported a case of corneal edema after
use of moxiﬂoxacin drops used to treat conjunctivitis cause cor-
neal edema with profound drop of vision which cleared after
cessation of the drops and return of vision, the prosed mecha-
nism here was that the drug can inhibit the synthesis of collagen
iv or damage to the Descemet’s membrane and its adjacent
endothelial layer causing toxicity appeared as corneal edema.
NSAID can cause upregulations of corneal matrix metallo-
proteases (MMPs) which will interfere with the corneal epithe-
lial defects healing (Mian et al., 2006).
Systemic medications can cause ocular depositions and tox-
icity, and the most famous drug is the Amiodarone (anti
arrhythmic drug) which can reach the eye through the tear ﬁlm
and limbal vessels and results in powder like deposition of dif-
ferent colors in the corneal basal epithelial and stromal cells
under the apex of the cornea appearing as whorle-like lines
called vortex keratopathy and causing drug-induced lipidosis
(Turk et al., 2015).
Our case had corneal toxicity in the form of delayed healing
of the epithelial defect with sick epithelial layer necessitating
epithelial debridement associated with moderate stromal inﬁl-
trates after wrong application of an analgesic ointment
designed for external use.
For our knowledge it is the ﬁrst report about such incident
regionally.
Drug dispensing (medication treatment process) involves
three stages: the prescription, the transcription and, ﬁnally
administration. In the prescription stage the health provider
such as a physician will write the medication and through a
pharmacist in the transcription stage the medication data will
be entered into the pharmacy database and the label is written.
Subsequently another pharmacist will double check the medi-
cation in the ﬁlling substage and ﬁnally a third pharmacist will
triple check the medication upon release to the patient.
The administration stage is when the patient uses the
released medication (Alsulami and Conroy, 2013 April).
Factors that may contribute to dispensing errors include:
negligence in correctly identifying the patient or medication,
for example, the name and medical record of the patient, name
of the drug, its strength, quantity, etc.; unclear physician hand
writing and/or incomplete prescription; lack of knowledge
and/or focus; limited or no patient counseling; distractions at
the work place; heavy workload; medication that looks similar
or similar sounding medications; miscommunication between
healthcare professionals.(Kundsen et al., 2007; Berdot et al.,
2012) The prescribed medication was eye drops (Tobradex)
whereas the medication handed over to the patient by the
pharmacist was a skin ointment (Tabiﬂex) to be used exter-
nally. The sizes of the eye drops pack, the skin ointment differs
and this, at least, should have alerted the pharmacist.
Some studies report the most common reason for dispens-
ing errors is similar sounding medication or medications that
appear similar (Kundsen et al., 2007; Berdot et al., 2012). A
study of community pharmacies reported that the errors
mostly occurred during the process of the transcription and
labeling of the medication (Kundsen et al., 2007).
According to the international accreditation standards,
health organizations should have a process in place where
the medication is reviewed by a pharmacist before dispensing.
Figure 1 Slit lamp photograph of the cornea shows an area of
corneal epithelial defect with surrounding area of toxic inﬁltration.
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Additionally, 2 or more pharmacy technicians should help in
checking the orders before dispensing by the pharmacist
(Alsultan et al., 2012).
In the current case, the error seemed to occur during label-
ing of the medication. The correctly prescribed medication
(Tobradex; Alcon Inc., Fort Worth, Tx., USA) was transcribed
and written correctly by the junior pharmacist or technician but
the wrong label was afﬁxed on the wrong medication (Tabiﬂex)
(Fig. 2b). In this case it occurred because the medication looks
similar which is a signiﬁcant and common cause of medication
error (Kundsen et al., 2007; Berdot et al., 2012). Similar to our
case, most medication errors do not have long term sequelae
(Mansouri et al., 2013). Our patient used 2 doses of the wrong
medication and was astute enough to discover it was not the
prescribed medication. The early discovery of the error was
likely a factor in limiting the duration and severity of
symptoms.
The clinical picture in our case could not be deﬁnitively
attributed to the effect of using the wrong medication because
corneal epithelial defect and inﬂammation are common after
trauma to the eye. However the symptoms and defect were
resolved quickly to topical steroid drops. The importance of
this case report is to highlight the processes for checking med-
ication prescriptions at pharmacies. Additionally, the safety
measures in place should be used for every patient as they will
mitigate ocular effects and also potentially more fatal systemic
effects of medication error. In conclusion errors in medication
dispensing and administration may be common but most have
no long term effects. However, these quality standards are fun-
damental at pharmacies to avoid the use and sometimes fatal
effects of wrongly administered medications.
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Figure 2a The label of the correct medication (Tobradex) prescribed by the ophthalmologist afﬁxed on the wrong medication pack
(Tabiﬂex).
Figure 2b The tube of the wrongly dispensed pain killer ointment (Tabiﬂex Cool). Removed from the packaging.
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